Protocol No.: GCT1184-07

A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer
Principal Investigator
Pfaendler, Krista
Phase
III (Cancer Control)
Age Group
Adult
Applicable Disease Site
Gynecologic Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Jill Stone, LPN
Research Specialist
Phone: +1 304-634-4417

View on ClinicalTrials.gov